Can gabapentin (Neurontin) cause abdominal pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Gabapentin Cause Abdominal Pain?

Gabapentin does not typically cause abdominal pain as a direct adverse effect; in fact, it is used therapeutically to reduce visceral abdominal pain in various gastrointestinal conditions. However, abrupt discontinuation of gabapentin can lead to withdrawal symptoms that include abdominal pain.

Gabapentin's Effect on Abdominal Pain

Therapeutic Use for Abdominal Pain

  • Gabapentin is specifically used to treat chronic visceral abdominal pain in conditions like gastroparesis, functional dyspepsia, and irritable bowel syndrome, where it provides pain relief through modulation of calcium channels and inhibition of excitatory neurotransmitter release 1.

  • In functional dyspepsia patients, gabapentin significantly improved upper abdominal pain subscores, with ≥50% of patients experiencing clinically meaningful improvement in pain symptoms 2.

  • For diarrhea-predominant IBS, gabapentin reduced rectal mechanosensitivity and increased pain thresholds for bloating, discomfort, and pain through attenuating rectal sensitivity to distension 3.

  • Gabapentin is recommended as a neuromodulator for chronic abdominal pain in IBD patients when used in combination with behavioral self-management, particularly for severe or chronic pain 1.

Common Side Effects (Not Including Abdominal Pain)

  • The FDA-approved labeling lists the most common adverse reactions as dizziness, somnolence, peripheral edema, dry mouth, constipation, nausea, vomiting, and diarrhea 4.

  • Gastrointestinal side effects documented in clinical trials include diarrhea (6%), dry mouth (5%), constipation (4%), nausea (4%), and vomiting (3%), but abdominal pain is not listed as a common adverse reaction 4.

  • Common side effects across multiple guidelines include dizziness, somnolence, dry mouth, and constipation, with no mention of abdominal pain as a typical adverse effect 1, 5.

Critical Caveat: Withdrawal-Related Abdominal Pain

  • Abrupt discontinuation of gabapentin can cause withdrawal symptoms that include abdominal pain, as documented in a case report where a patient developed confusion, agitation, and other symptoms after gabapentin was stopped, which completely resolved upon reinitiation 6.

  • Withdrawal symptoms typically begin 2-3 days after discontinuation and may include restlessness, disorientation, confusion, agitation, anxiety, headache, and light sensitivity in addition to potential abdominal discomfort 6.

Clinical Context for Postoperative Pain

  • In postoperative settings, gabapentin reduces rather than causes abdominal pain, with studies showing decreased morphine requirements and lower pain scores following lower abdominal surgery 7, 8.

  • Pre-emptive gabapentin 600 mg given two hours before non-obstetric lower abdominal surgery significantly reduced postoperative pain (VAS scores) and total morphine requirements (2.47 mg vs 5.33 mg in placebo; P < 0.001) 8.

Practical Recommendations

  • If a patient on gabapentin develops new abdominal pain, consider alternative etiologies first rather than attributing it to the medication, as this is not a recognized direct adverse effect 4.

  • When discontinuing gabapentin, taper gradually rather than stopping abruptly to avoid withdrawal symptoms including potential abdominal discomfort 6.

  • For patients with chronic visceral abdominal pain, gabapentin at doses >1200 mg daily in divided doses can provide therapeutic benefit, though selective outcome reporting in industry-sponsored trials has raised some questions about the evidence quality 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mechanism of Action and Pharmacokinetics of Pregabalin and Gabapentin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Withdrawal symptoms after gabapentin discontinuation.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.